RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Karl E. Klose to Genetic Vectors

This is a "connection" page, showing publications Karl E. Klose has written about Genetic Vectors.
Connection Strength

0.917
  1. Mejia-Santana A, Lloyd CJ, Klose KE. New cloning vectors to facilitate quick allelic exchange in gram-negative bacteria. Biotechniques. 2021 02; 70(2):116-119.
    View in: PubMed
    Score: 0.739
  2. Karna SL, Zogaj X, Barker JR, Seshu J, Dove SL, Klose KE. A bacterial two-hybrid system that utilizes Gateway cloning for rapid screening of protein-protein interactions. Biotechniques. 2010 Nov; 49(5):831-3.
    View in: PubMed
    Score: 0.091
  3. Rodriguez SA, Yu JJ, Davis G, Arulanandam BP, Klose KE. Targeted inactivation of francisella tularensis genes by group II introns. Appl Environ Microbiol. 2008 May; 74(9):2619-26.
    View in: PubMed
    Score: 0.076
  4. Ryan ET, Crean TI, Kochi SK, John M, Luciano AA, Killeen KP, Klose KE, Calderwood SB. Development of a DeltaglnA balanced lethal plasmid system for expression of heterologous antigens by attenuated vaccine vector strains of Vibrio cholerae. Infect Immun. 2000 Jan; 68(1):221-6.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support